S100B and type 2 diabetes mellitus: To our knowledge, the present study is the first to report circulating concentrations of sRAGE with the RAGE ligands AGEs, S100B, S100A1 and S100A6 in the context of young, healthy human individuals and middle-aged individuals who are either healthy, have impaired glucose tolerance, or T2D.